Tuesday
06.22.2021
9:49 AM
Login form
Search
Calendar
Entries archive

My site

Main » 2021 » April » 18

SLIEMA, Malta-Saturday 17 April 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Cryptology Asset Group p.l.c. (ISIN: MT0001770107; Ticker: CAP), a leading European investment company for blockchain- and crypto-related business models, has successfully completed its cash capital increase by issuing 128,375 new shares and the additional sale of the entire amount of 31,625 treasury shares to institutional investors. At a fixed price of EUR 200.00 per share each, the Company will receive total gross proceeds of EUR 32.0 million, which will be used to invest in new portfolio companies from the Cryptology pipeline. The Company is also exploring the possible acquisition of crypto assets, such as Bitcoin, as part of its treasury management strategy.

To finance further growth, Cryptology is also currently reviewing various options to raise additional capital, such as through the issuance of a convertible or a straight bond. ICF BANK AG has been commissioned to conduct a market review. ... Read more »

Views: 5 | Added by: africa-live | Date: 04.18.2021 | Comments (0)

CHARLOTTE, N.C.-Saturday 17 April 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Bank of America reported its first-quarter 2021 financial results today. The news release, supplemental filing and investor presentation can be accessed in the following ways:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210415005486/en/

Bank of America newsroom at https://newsroom.bankofamerica.com
Q1-21 Bank of America Financial Results Press Release
Q1-21 Bank of America Investor Relations Presentation
Q1-21 Bank of America Supplemental Information
Bank of America Investor Relations website at https://investor.bankofamerica.com
Business Wire’s news webpage at http://www.businesswire.com/portal/site/home/news
 

Investor Conference Call information:

Chief Executive Officer Brian Moynihan and Chief Financial Officer Paul Donofrio will discuss the financial results ... Read more »

Views: 5 | Added by: africa-live | Date: 04.18.2021 | Comments (0)

MUNICH-Friday 16 April 2021 [ AETOS Wire ]

 

(BUSINESS WIRE) -- VertiGIS, a leading geographic information systems (GIS) solution provider and software developer, announced today the completed acquisition of longstanding development partner KMS Computer GmbH. KMS is an established and trusted computer-aided facility management (CAFM) software specialist based in Dresden, Germany.

VertiGIS is backed by global, technology-based investment firm Battery Ventures, who began acquiring GIS ... Read more »

Views: 11 | Added by: africa-live | Date: 04.18.2021 | Comments (0)

MORRISVILLE, N.C.-Friday 16 April 2021 [ AETOS Wire ]

 

(BUSINESS WIRE) -- Today, during its annual global employee kickoff event broadcast to 63,000 employees, Lenovo unveiled its plans to drive transformation from a global devices company to a technology leader in global devices + solutions, services, and software. Lenovo CEO Yang Yuanqing and other executive leaders outlined the company’s strategy, structure, and goals that will fuel Lenovo’s next decade of growth and position it as one of the world’s most trusted and iconic technology leaders, delivering smarter technology for a ... Read more »

Views: 11 | Added by: africa-live | Date: 04.18.2021 | Comments (0)

• Data presented at AAN shows investigational evobrutinib significantly reduced blood neurofilament light chain (NfL) levels, which may predict future brain atrophy and disease progression, in patients with relapsing MS

• Additional data from the Phase II study to be presented at triMS.online conference will report evobrutinib concentrations in the cerebrospinal fluid of patients with MS


DARMSTADT, Germany-Friday 16 April 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Merck, a leading science and technology company, will present data from a Phase II placebo-controlled randomized trial at the 2021 American Academy of Neurology (AAN) Annual Meeting showing that the investigational Bruton’s tyrosine kinase (BTK) inhibitor evobrutinib significantly reduced blood neurofilament light chain (NfL) levels, a key biomarker of neuronal damage and inflammation, in patients with multiple sclerosis (MS). Elevated blood NfL levels have been shown to be associ ... Read more »

Views: 5 | Added by: africa-live | Date: 04.18.2021 | Comments (0)

 Goal to Use 100% Recycled, Recyclable or Bio-based Plastic Materials across all Matchbox® Cars, Playsets and Packaging by 2030

 

EL SEGUNDO, Calif.-Friday 16 April 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- Today, Mattel, Inc. (NASDAQ: MAT) announced Drive Toward a Better Future, its product roadmap to make all Matchbox die-cast cars, playsets and packaging with 100% recycled, recyclable or bio-based plastic by 2030. This is in line with Mattel’s goal to achieve 100% recycled, recyclable or bio-based plastic materials across all its products and packaging by 2030.

To illustrate these principles, Mattel is unveiling the Matchbox Tesla Roadster, its first die-cast vehicle made from 99% recycled materials and certified CarbonNeutral®*. The Matchbox Tesla Roadster will be available starting in 2022.

The reimagined broader Matchbox brand includes new product lines and packaging that feature:

    More envi ... Read more »

Views: 5 | Added by: africa-live | Date: 04.18.2021

SAN CARLOS, Calif.-Friday 16 April 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodies with enhanced biological function for an undisclosed oncology target.

Under the terms of the agreement RubrYc and Zai Labs will collaborate to identify product candidates using RubrYc’s Discovery Engine, which leverages machine learning and structural data to identify antibodies that bind to subdominant epitopes and exhibit differentiated activity. Upon exercise of the license option Zai Labs would have exclusive global rights to develop and commercialize product(s) of the Research Collaboration.

RubrYc Therapeutics, Inc. will receive an upfront payment ... Read more »

Views: 7 | Added by: africanewsline | Date: 04.18.2021 | Comments (0)